Back
Morguard North American Residential Real Estate Investment Trust Vs. Agios Pharmaceuticals Industry Stock Comparison
Sell
45
MNARF
Morguard North American Residential Real Estate Investment Trust
Last Price:
$11.97
Seasonality Move:
9.12%
Sell
8
AGIO
Agios Pharmaceuticals
Last Price:
$32.16
Seasonality Move:
10.13%
Sell
45
Morguard North American Residential Real Estate Investment Trust (MNARF)
is a Sell
Is Morguard North American Residential Real Estate Investment Trust a Buy, Sell or Hold?
-
The current Morguard North American Residential Real Estate Investment Trust [MNARF] share price is $11.97. The Score for MNARF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
MNARF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
8
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
-
The current Agios Pharmaceuticals [AGIO] share price is $32.19. The Score for AGIO is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
-
AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
MNARF Stock Price Chart
What is Morguard North American Residential Real Estate Investment Trust's stock price today?
-
The Morguard North American Residential Real Estate Investment Trust share price today is $11.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNARF is experiencing slight buying pressure.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $32.19Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing slight buying pressure.
MNARF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.33 | Sell |
Relative Strength Index (14 RSI): | 26.66 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.96 - 13.22) | Sell |
Bollinger Bands (100): | (12.39 - 13.93) | Sell |
AGIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.19 | Sell |
Relative Strength Index (14 RSI): | 26.3 | Sell |
Chaikin Money Flow: | 119640 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.09 - 54.37) | Sell |
Bollinger Bands (100): | (39.22 - 53.24) | Sell |
MNARF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.84 | Buy |
20-day SMA: | 12.47 | Sell |
50-day SMA: | 12.87 | Sell |
200-day SMA: | 12.45 | Sell |
8-day EMA: | 11.98 | Sell |
20-day EMA: | 12.3 | Sell |
50-day EMA: | 12.72 | Sell |
200-day EMA: | 12.55 | Sell |
AGIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.4 | Sell |
20-day SMA: | 39.89 | Sell |
50-day SMA: | 47.81 | Sell |
200-day SMA: | 42.22 | Sell |
8-day EMA: | 33.87 | Sell |
20-day EMA: | 39 | Sell |
50-day EMA: | 44.23 | Sell |
200-day EMA: | 41.89 | Sell |
Morguard North American Residential Real Estate Investment Trust Earnings Growth & MNARF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, a decrease this year of $16.90 per share, and an increase next year of $0.54 per share.
Morguard North American Residential Real Estate Investment Trust Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Agios Pharmaceuticals Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |